Early Detection Research Network

CD1A

Aliases:
This biomarker is also known as:
  • CD1A,
  • T-cell surface antigen T6/Leu-6,
  • cortical thymocyte antigen CD1A,
  • HTA1,
  • CD1a antigen,
  • CD1a molecule,
  • T6,
  • cluster of differentiation 1 A,
  • T-cell surface glycoprotein CD1a,
  • R4,
  • CD1,
  • CD1A antigen, a polypeptide,
  • FCB6,
  • differentiation antigen CD1-alpha-3,
  • hTa1 thymocyte antigen,
  • epidermal dendritic cell marker CD1a,

Description…

CD1A is a transmembrane glycoprotein that is structurally related to the major histocompatibility complex (MHC) proteins and forms heterodimers with beta-2-microglobulin. CD1A functions as an antigen-presenting protein that binds self and non-self lipid and glycolipid antigens and presents them to T-cell receptors on natural killer T-cells.

Datasets

There are no datasets associated with this biomarker.

Attributes
QA State: Curated
Type: Protein
HGNC Name: CD1A

The following organs have data associated with this biomarker…

Attributes

Phase: Two
QA State: Under Review

Overview

No additional breast data available.

Performance Comment

CD1A was one of numerous potential early detection biomarkers specific to triple-negative breast cancer in multiple pathways identified.

This biomarker is currently being annotated or is under review. You must be logged in or do not have permission to view any additional information. Contact Heather Kincaid at heather.kincaid@jpl.nasa.gov if you should have access to this biomarker.

No associated publications found.